The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Uranium and lithium investment opportunities will be showcased at the RIU Resurgence conference that starts in Perth tomorrow, and it’s not too late for interested investors to commit to coming along.

Tomorrow there’ll be two Uranium ‘Power Sessions’ featuring companies in 15-minute slots including Deep Yellow (ASX:DYL); Aurora Energy Metals (ASX:1AE); GTI Energy (ASX:GTR); Aura Energy (ASX:AEE); Toro Energy (ASX:TOE); 92 Energy (ASX:92E); Peninsula Energy (ASX:PEN); Basin Energy (ASX:BSN); Okapi Resources (ASX:OKR); Cauldron Energy (ASX:CXU); Valor Resources (ASX:VAL); Haranga Resources (ASX:HAR); Bannerman Energy (ASX:BMN); and, NexGen Energy (ASX:NXG).

Uranium’s rally

Given the “resurgence” in uranium this year, Jaxon Crabb from Vertical Events, the conference organiser, said it was fitting for the event’s focus.

“It’s not just the price of uranium, it’s the dialogue that’s coming out of certain governments, it’s about being proactive around initiating new nuclear reactors, and you know that all the next wave of reactors are going to be safer,” he said.

“Uranium will hopefully be a major component in bringing carbon emissions down in the future, as will hopefully lithium and the whole EV space.”

Lithium, battery metals & gold

Numerous lithium, battery metals and some gold companies will also present over the two days and the closing panel topic on Thursday will be ‘Lithium and Uranium: Can they work together to reduce carbon emissions?’.

About 35 ASX-listed resources companies will be represented, with brokers and investors attending.

There’s no cost for retail investors, stock brokers or fund managers who are not employed in the resources industry to register.

More From The Market Online
The Market Online Video

Market Close: Consumer stocks drag market lower; Alara starts copper production in Oman

The ASX200 has closed the day down 0.15 per cent at 7724 points.
The Market Online Video

Orcoda welcomes Maree Adshead as Non-Executive Director

Orcoda (ASX:ODA) has welcomed Maree Adshead as an independent Non-Executive Director.

Cynata Therapeutics advances Phase 2 trial for high-risk aGvHD treatment

The market has responded favourably to Cynata Therapeutics' announcement regarding its Phase 2 clinical trial on…
The Market Online Video

Market Update: ASX trades flat as materials leads the market

The ASX200 is trading flat this afternoon, up just .10 of a per cent in line…